The Dermatology Digest

FEBRUARY 5, 2025

We are proud to collaborate with DEBRA Research, whose vast experience in the pharmaceutical industry and commitment to advancing medical research are invaluable. At LEO Pharma, we build partnerships that help us stay on the lookout and contribute our expertise to the next advancements. Together, we can do so much more.

Partnerships 65

Partnerships Treatments Pharmaceutical Office 65

The Dermatology Digest

FEBRUARY 23, 2025

Food and Drug Administration (FDA) approved chenodiol ( Ctexli , Mirum Pharmaceuticals Inc.) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Chenodiol is the first FDA-approved drug to treat CTX, a very rare lipid storage disease.

Treatments 53

Treatments Pharmaceutical Clinic Dermatology 53

Lipgloss and Aftershave

APRIL 9, 2025

This innovation became known as Permeation Enhancement Technology (P.E.T.) , and in 2002, it powered an FDA-approved pharmaceutical product. This FDA-approved tech was developed for pharmaceuticals and now powers the penetration of heavyweight molecules like peptides, growth factors, and vitamins deep into the skin.

Pharmaceutical 52

Pharmaceutical Skincare Brands Technology Therapy 52

The Dermatology Digest

JANUARY 23, 2024

LEO Pharma now owns TMB-001 as well as certain other assets from Timber Pharmaceuticals following its chapter 11 bankruptcy filing. All employees of Timber Pharmaceuticals will transition to LEO Pharma’s offices in New Jersey, US, the Company reports. The TMB-001 project continues as planned and without changes within LEO Pharma.

Pharmaceutical 36

Pharmaceutical Office Ingredients Therapy 36

Spa Executive

NOVEMBER 18, 2024

.” Li, director of Waterloo’s Printable Electronic Materials Lab, said in a statement: “AI technology is evolving rapidly, offering sophisticated signal analysis for health monitoring, food and pharmaceutical storage, environmental monitoring, and more.

Technology 52

Technology Pharmaceutical Innovations Marketing 52

Lipgloss and Aftershave

FEBRUARY 17, 2025

He has authored a textbook on Aesthetic Medicine, published over 35 scientific papers, and serves as a Global Advisor for major pharmaceutical companies. Wong is a highly respected figure in the aesthetic medicine industry.

Medical 52

Medical Pharmaceutical Injections Surgery 52

The Dermatology Digest

MARCH 26, 2024

Verrica Pharmaceuticals Inc.’s The post Verrica Pharmaceuticals’ YCANTH Receives New Chemical Entity Status, Orange Book Listing From FDA appeared first on The Dermatology Digest. s YCANTH now has New Chemical Entity (NCE) Status and a listing in the Orange Book from the U.S. YCANTH (cantharidin) topical solution, 0.7%

Pharmaceutical 36

Pharmaceutical Portfolios Office Marketing 36

The Dermatology Digest

NOVEMBER 25, 2024

Jerry Tan, MD, is joining Derm-Biome Pharmaceuticals, Inc.’s s Scientific Advisory Board.

Pharmaceutical 36

Pharmaceutical Collagen Scarring Rosacea 36

Dermatology Times

OCTOBER 3, 2024

This expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions

Pharmaceutical 78

Pharmaceutical 78

Dermatology Times

MAY 7, 2024

ASLAN Pharmaceuticals presented new data this morning, including a 90% EASI score reduction.

Pharmaceutical 74

Pharmaceutical 74

The Dermatology Digest

APRIL 3, 2024

Ligand Pharmaceuticals is launching Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and has appointed Scott Plesha as Chief Executive Officer to accelerate the commercialization of berdazimer topical gel, 10.3% (Zelsuvmi) for the treatment of molluscum contagiosum. in September 2023.

Pharmaceutical 36

Pharmaceutical Sales Office Partnerships 36

The Dermatology Digest

FEBRUARY 27, 2024

Pelage Pharmaceuticals has closed a $16.75 We have uncovered a small molecule able to stimulate cellular metabolism to re-awaken hair follicle stem cells and spur new hair growth,” says William Lowry, PhD, scientific co-founder, Pelage Pharmaceuticals, in a news release.

Pharmaceutical 36

Pharmaceutical Treatments Hospital Clinic 36

Dermatology Times

APRIL 27, 2024

Keep up with the latest headlines in dermatology from the past week, including the appointment of All Detergent's first chief dermatology advisor, Incyte's acquisition of Escient Pharmaceuticals, and more.

Pharmaceutical 74

Pharmaceutical Dermatology 74

Dermatology Times

AUGUST 14, 2024

Myron Czuczman, MD, of Citius Pharmaceuticals recently shared perspectives on the role and potential of Lymphir in CTCL.

Pharmaceutical 71

Pharmaceutical 71

Dermatology Times

JANUARY 26, 2024

ICYMI, this week we had news about the completion of LEO Pharma's acquisition of Timber Pharmaceuticals, research pointing to melanoma overdiagnosis in White patients, artificial intelligence in skin cancer detection, and more.

Pharmaceutical 78

Pharmaceutical 78

Alison Bladh

JANUARY 21, 2025

Current Pharmaceutical Design , 17(8), pp.754768. New England Journal of Medicine , 368(14), pp.12791290. DOI: 10.1056/NEJMoa1200303. Russell, A. and Keast, R., Oleocanthal: A naturally occurring anti-inflammatory agent in extra virgin olive oil. DOI: 10.2174/138161211795428910. Fernndez-Real, J.M., Prez-Fernndez, R., Lpez-Bermejo, A.

Diet 97

Diet Pharmaceutical Marketing Management 97

Dermatology Times

FEBRUARY 29, 2024

The collaboration with Sato marks a continued effort of Arcutis to collaborate with pharmaceutical companies and license topical roflumilast in Asia.

Pharmaceutical 73

Pharmaceutical 73

The Dermatology Digest

DECEMBER 27, 2024

Johnson & Johnson has entered into an exclusive licensing agreement for the global development, manufacturing and commercialization of a STAT6 program for autoimmune and allergic diseases, including atopic dermatitis (AD), from Kaken Pharmaceutical.

Dermatitis 36

Dermatitis Portfolios Pharmaceutical Innovations 36

Renee Rouleau

JANUARY 19, 2024

Pharmaceutical and Medical Advancements Ingredients that have been traditionally used for non-skincare purposes are now finding their way into the beauty industry. For example, witch hazel , previously used in wound healing and as a vasoconstrictor in modern medicine, is now used for soothing the skin and reducing excess oil production.

Skincare 195

Skincare Innovations Ingredients Esthetician 195

Lipgloss and Aftershave

NOVEMBER 15, 2024

Phyllis Hsieh is the visionary behind Conrex Pharmaceutical Corp. The Permeation Enhancement Technology is FDA-approved in pharmaceuticals. and the creator of SESHA SKIN THERAPY, a professional skincare brand powered by Patented enhancement technology (P.E.T ) technology.

Management 40

Management Microneedling Therapy Pharmaceutical 40

Dermatology Times

JUNE 21, 2024

Botanix Pharmaceuticals announced the approval of its sofpironium topical gel, 12.45% for adults and children ages 9 and older.

Pharmaceutical 62

Pharmaceutical 62

The Dermatology Digest

NOVEMBER 30, 2024

LP-310, developed by Lipella Pharmaceuticals for the treatment of oral lichen planus (OLP), is currently in Phase 2 clinical trials. There are currently no drugs specifically approved for lichen planus and available treatments are primarily palliative.

Pharmaceutical 36

Pharmaceutical Safety Marketing Therapy 36

Dermatology Times

AUGUST 26, 2023

Keep up with the latest headlines in dermatology from the past week, including growing concerns of a dermatologist shortage in Ontario, LEO Pharma's acquisition of Timber Pharmaceuticals, and more. This week, we have also included a patient-forward rundown of top headlines to share with your patients.

Pharmaceutical 69

Pharmaceutical Dermatology 69

Kim Gallo Esthetics

MAY 31, 2023

Also known as pharmaceutical-grade , medical-grade skincare is exactly what it sounds like - products that are both developed and tested by medical professionals. Keep reading to find out why medical-grade skincare works better and which brand of professional-grade product is right for you. What is medical-grade skincare?

Medical Grade Skincare 195

Medical Grade Skincare Medical Skincare Esthetics 195

The Dermatology Digest

MARCH 10, 2025

Tildrakizumab-asmn (Ilumya, Sun Pharmaceutical Industries, Inc.) improves moderate-to-severe nail psoriasis, according to new research presented at the 2025American Academy of Dermatology(AAD) Annual Meeting in Orlando, FL.

Pharmaceutical 36

Pharmaceutical Safety Clinic Injections 36

The Dermatology Digest

MARCH 28, 2025

Quoin Pharmaceuticals has filed a U.S. patent application for novel topical formulations to treat several skin diseases, including Netherton Syndrome (NS). Quoins lead product, QRX003, is currently being tested in four Netherton Syndrome clinical trials.

Pharmaceutical 36

Pharmaceutical Clinic Hospital Office 36

The Dermatology Digest

JANUARY 29, 2024

Medicaid and Medicare patient populations,” says Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, in a news release. “In “By securing a permanent J-Code for YCANTH, we have successfully reached a critical milestone in our commercial strategy that we expect will help us accelerate YCANTH utilization among the U.S.

Pharmaceutical 74

Pharmaceutical Office Medical Management 74

The Dermatology Digest

NOVEMBER 6, 2024

PeDRA thanks AbbVie and Sanofi & Regeneron Pharmaceuticals for their support of 2024 EIRGs. Awardees received a budget to cover project and living expenses and a stipend to attend the 2024 PeDRA Annual Conference. The post PeDRA Launches Two New Grant Programs, Announces 2024 EIRG Recipients appeared first on The Dermatology Digest.

Pharmaceutical 36

Pharmaceutical Hospital Dermatology Medical 36

The Dermatology Digest

SEPTEMBER 12, 2024

In 2011, Mr. Clark co-founded and served as President and CEO of Clark Pharmaceuticals, where he launched and sold several more over-the-counter dermatology products. His passing is a true loss to the dermatology world, as his contributions helped treat millions of people with skin diseases.

Dermatology 74

Dermatology Pharmaceutical Skincare 74

Lipgloss and Aftershave

FEBRUARY 21, 2025

He has authored a textbook on Aesthetic Medicine, published over 35 scientific papers, and serves as a Global Advisor for major pharmaceutical companies. Wong is a highly respected figure in the aesthetic medicine industry.

Facials 52

Facials Hydration Injections Innovations 52

The Dermatology Digest

NOVEMBER 5, 2024

Sun Pharma acquired deuruxolitinib when it purchased Concert Pharmaceuticals in March 2023 and received the U.S, Deuruxolitinib is a deuterated form of ruxolitinib. In the lawsuit, Incyte states that the patent covers claims on deuterated forms of the compound. The post Patent Dispute Update: Incyte Blocks U.S.

Pharmaceutical 36

Pharmaceutical Dermatitis Dermatology 36

Dermatology Times

JANUARY 6, 2025

The results showed promising improvements in all endpoints with high patient satisfaction and no safety concerns.

Pharmaceutical 31

Pharmaceutical Safety 31

Dermatology Times

DECEMBER 19, 2024

The "whole body" study at Northwestern will be lead by Amy Paller, MD, begins soon.

Pharmaceutical 31

Pharmaceutical 31

The Dermatology Digest

FEBRUARY 8, 2024

Dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc., Food and Drug Administration (FDA) recently OKed a label update for dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc., Immunotherapy including cemiplimab (Libtayo, Regeneron Pharmaceuticals) has also brought hope to even the most difficult tumors,” he says.

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

The Dermatology Digest

MAY 15, 2024

Verrica Pharmaceuticals Inc. has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. FDA and Japan’s Pharmaceuticals and Medical Device Agency (PMDA) on the proposed design of the Phase 3 clinical trial. With a prevalence of approximately 22 million patients in the U.S.

Pharmaceutical 36

Pharmaceutical Clinic Sales Dermatology 36

The Dermatology Digest

DECEMBER 30, 2024

The 20th Annual SOCS Scientific Symposium was generously supported by the following sponsors: AbbVie, Johnson & Johnson, Sanofi and Regeneron Pharmaceuticals, Inc. Taylor, a dermatologist in Philadelphia, PA. Champion); Bristol Myers Squibb, Eli Lilly, Inc.,

Webinar 78

Webinar Education Social Media Dermatology 78

The Dermatology Digest

AUGUST 21, 2024

Food and Drug Administration, according to Leo Pharma and Timber Pharmaceuticals. LEO Pharma acquired TMB-001 from Timber Pharmaceuticals in January 2024 following Timber’s Chapter 11 bankruptcy filing. As a consequence of the acquisition, Timber Pharmaceuticals was reformed as a fully owned subsidiary of LEO Pharma.

Pharmaceutical 36

Pharmaceutical Clinic Office Dermatology 36